home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  February 24, 2018
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 586 active entries

IBT-Immunological and Biochemical Testsystems GmbH

Wiesenstr. 17
D-88521 Binzwangen, Germany
Germany

Phone: +49 7371 9522000
Fax: +49 7371 9522007
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Description:

 

ibt develops, manufactures and distributes immunological reagents: recombinant proteins and antibodies (e.g.for research in infectious diseases, transcription, growth factors, chemokines and cytokines). A new focus is on development, manufacturing and distribution of immunoassay kits for Insulin-like Growth Factors (IGF's) and Insulin-like Growth Factor Binding Proteins (IGFBP's) and related molecules. Our new biotinylation technology ensures full biological activity of the molecules. Applications of biotinylated IGF´s and other peptides and proteins are in western-ligand blotting, ELISA, protease assays, IHC, immunoprecipitation, cross-linking, cell sorting, immunohistochemistry, receptor binding and internalization studies, experimental cell therapy and tissue regeneration.

 

For more information please take a look on our website at www.ibtsystems.de.



Selected Categories:
Product Company   Service Company
Biotech
- General
Diagnostics
- Immunoassay
- in vitro
- Miscellaneous
Supplier
- Distributor
- Research
Contract
- Services

Last update of this entry: August 09, 2016

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.